Accuray is a radiation oncology company. Co.'s technologies are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy and adaptive radiation therapy tailored to the needs of each patient. Co.'s products include the CyberKnife® Systems and TomoTherapy® Systems. The CyberKnife Systems are robotic stereotactic radiosurgery systems and stereotactic body radiation therapy systems used to treat multiple types of cancer and tumors. The TomoTherapy Systems are used to treat a range of cancers and tumors, and enable daily imaging to ensure the accuracy of the patient position before each treatment delivery.
ARAY — Key Stats (updated Monday, March 3, 10:50 AM)
Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Service. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20
minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.